A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection. AIDS Clinical Trials Group 330 Team (Q45750397)
Jump to navigation
Jump to search
scientific article published in April 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection. AIDS Clinical Trials Group 330 Team |
scientific article published in April 1999 |
Statements
1 reference
A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection. AIDS Clinical Trials Group 330 Team (English)
1 reference
M W Kline
1 reference
S Blanchard
1 reference
C V Fletcher
1 reference
J L Shenep
1 reference
R E McKinney
1 reference
R C Brundage
1 reference
M Culnane
1 reference
R B Van Dyke
1 reference
W M Dankner
1 reference
A Kovacs
1 reference
J A McDowell
1 reference
S Hetherington
1 reference
1 April 1999
1 reference
1 reference
103
1 reference
4
1 reference
e47
1 reference